Literature DB >> 12604207

Human class IV alcohol dehydrogenase: kinetic mechanism, functional roles and medical relevance.

Shih-Jiun Yin1, Chu-Fang Chou, Ching-Long Lai, Shou-Lun Lee, Chih-Li Han.   

Abstract

Human alcohol dehydrogenase (ADH) constitutes a complex family. Class IV ADH (ADH4) is characteristic in its epithelial expression in the aerodigestive tract and high V(max) and K(m) for oxidation of ethanol. ADH4 exhibits the highest catalytic efficiency for retinol oxidation in human ADH family. Initial velocity, product inhibition, and dead-end inhibition studies indicate that ADH4, when functioning as ethanol dehydrogenase, conforms to an ordered sequential mechanism with coenzyme binding first and releasing last in catalytic cycle. When functioning as retinol dehydrogenase, the mechanism of ADH4 deduced from steady-state kinetic and equilibrium-binding studies is best described as a rapid equilibrium random mechanism with two dead-end ternary complex for retinol oxidation and a rapid equilibrium ordered mechanism with one dead-end ternary complex for retinal reduction, a unique mechanistic form for zinc-containing ADHs in the medium chain dehydrogenase/reductase superfamily. Kinetic and genetic studies support the proposal that ADH4 may play two important physiological roles, i.e., as a major contributor to first-pass metabolism of ethanol in stomach as well as involvement in the synthesis of retinoic acid, a hormonal ligand controlling a nuclear receptor signaling pathway that regulates growth, development, and epithelial maintenance. Quantitative simulation studies indicate that retinol metabolism through ADH pathway can be inhibited to a significant extent during alcohol consumption. The perturbation of retinoic acid synthesis by ethanol may underlie the pathogenesis of fetal alcohol syndrome and alcohol-related upper digestive tract cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12604207     DOI: 10.1016/s0009-2797(02)00167-9

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  10 in total

1.  Hominids adapted to metabolize ethanol long before human-directed fermentation.

Authors:  Matthew A Carrigan; Oleg Uryasev; Carole B Frye; Blair L Eckman; Candace R Myers; Thomas D Hurley; Steven A Benner
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-01       Impact factor: 11.205

2.  Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk.

Authors:  Ellen L Goode; Kristin L White; Robert A Vierkant; Catherine M Phelan; Julie M Cunningham; Joellen M Schildkraut; Andrew Berchuck; Melissa C Larson; Brooke L Fridley; Janet E Olson; Penelope M Webb; Xiaoqing Chen; Jonathan Beesley; Georgia Chenevix-Trench; Thomas A Sellers
Journal:  Mol Carcinog       Date:  2010-12-28       Impact factor: 4.784

3.  Metabolism of Enantiomers of Rhododendrol in Human Skin Homogenate.

Authors:  Lihao Gu; Kazuhisa Maeda
Journal:  Metabolites       Date:  2022-05-03

4.  Contribution of NADH increases to ethanol's inhibition of retinol oxidation by human ADH isoforms.

Authors:  Jennifer R Chase; Mark G Poolman; David A Fell
Journal:  Alcohol Clin Exp Res       Date:  2009-01-16       Impact factor: 3.455

5.  Alcohol dehydrogenase (ADH) isoenzymes and aldehyde dehydrogenase (ALDH) activity in the sera of patients with gastric cancer.

Authors:  Wojciech Jelski; Lech Chrostek; Bogdan Zalewski; Maciej Szmitkowski
Journal:  Dig Dis Sci       Date:  2008-01-30       Impact factor: 3.199

6.  Single-nucleotide polymorphisms interact to affect ADH7 transcription.

Authors:  Sowmya Jairam; Howard J Edenberg
Journal:  Alcohol Clin Exp Res       Date:  2014-02-11       Impact factor: 3.455

7.  An enhancer-blocking element regulates the cell-specific expression of alcohol dehydrogenase 7.

Authors:  Sowmya Jairam; Howard J Edenberg
Journal:  Gene       Date:  2014-06-24       Impact factor: 3.688

Review 8.  Alcohol dehydrogenase and aldehyde dehydrogenase in malignant neoplasms.

Authors:  Karolina Orywal; Maciej Szmitkowski
Journal:  Clin Exp Med       Date:  2016-02-17       Impact factor: 3.984

9.  Characterization of Hepatitis B Virus Integrations Identified in Hepatocellular Carcinoma Genomes.

Authors:  Pranav P Mathkar; Xun Chen; Arvis Sulovari; Dawei Li
Journal:  Viruses       Date:  2021-02-04       Impact factor: 5.048

10.  Integrative analysis of the plasma proteome and polygenic risk of cardiometabolic diseases.

Authors:  Scott C Ritchie; Samuel A Lambert; Matthew Arnold; Shu Mei Teo; Sol Lim; Petar Scepanovic; Jonathan Marten; Sohail Zahid; Mark Chaffin; Yingying Liu; Gad Abraham; Willem H Ouwehand; David J Roberts; Nicholas A Watkins; Brian G Drew; Anna C Calkin; Emanuele Di Angelantonio; Nicole Soranzo; Stephen Burgess; Michael Chapman; Sekar Kathiresan; Amit V Khera; John Danesh; Adam S Butterworth; Michael Inouye
Journal:  Nat Metab       Date:  2021-11-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.